ABEC 4000升单次使用生物反应器扩大了Emergent BioSolutions的制造产能
Press ReleasesBethlehem, PA, USA, October 24, 2017- ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced that Emergent BioSolutions will equip their Baltimore, Maryland bulk manufacturing facility (Bayview), designated a Center for Innovation in Advanced Development and Manufacturing (CIADM), with an ABEC 4,000L CSR bioreactor. The system will be custom designed to Emergent’s process needs, operational requirements, and facility constraints, and will greatly expand cell culture capacity at the Bayview site.
ABEC公司
我们为生物制药生产提供整体解决方案和服务。
本网站使用cookies。继续浏览本站,即表示您同意我们使用cookies。更多信息,请查看我们的隐私政策。
公司总部
加入我们的时事通讯
现在就注册,第一时间收到ABEC新闻和行业动态!